In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV

被引:5
|
作者
Udofia, Inemesit A. [1 ]
Gbayo, Kofoworola O. [1 ]
Oloba-Whenu, Oluwakemi A. [1 ]
Ogunbayo, Taofeek B. [1 ]
Isanbor, Chukwuemeka [1 ]
机构
[1] Univ Lagos, Dept Chem, Lagos, Nigeria
关键词
COVID-19; Molecular docking; Antiviral drugs; Binding energy; Ligand binding interaction; ANTIVIRAL DRUGS;
D O I
10.1007/s13721-021-00299-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
An outbreak of a cluster of viral pneumonia cases, subsequently identified as coronavirus disease 2019 (COVID-19), due to a novel SARS-CoV-2 necessitates an urgent need for a vaccine to prevent infection or an approved medication for a cure. In our in silico molecular docking study, a total of 173 compounds, including FDA-approved antiviral drugs, with good ADME descriptors, and some other nucleotide analogues were screened. The results show that these compounds demonstrate strong binding affinity for the residues at the active sites of RNA-dependent RNA-polymerase (RdRp) modelled structures and Chymotrypsin-like cysteine protease (3CLpro) of the HCoV proteins. Free energies (AG's) of binding for SARS-CoV-2 and SARS-CoV RdRp range from - 5.4 to - 8.8 kcal/mol and - 4.9 to - 8.7 kcal/mol, respectively. Also, SARS-CoV-2 and SARS-CoV 3CLpro gave AG values ranging from - 5.1 to - 8.4 kcal/mol and - 5.5 to - 8.6 kcal/mol, respectively. Interesting results are obtained for ivermectin, an antiparasitic agent with broad spectrum activity, which gave the highest binding energy value (- 8.8 kcal/mol) against the 3CLpro of SARS-CoV-2 and RdRps of both SARS-CoV and SARS-CoV-2. The reason for such high binding energy values is probably due to the presence of hydroxy, methoxy and sugar moieties in its structure. The stability of the protein-ligand complexes of polymerase inhibitors considered in this investigation, such as Sofosbuvir, Remdesivir, Tenofovir, Ribavirin, Galidesivir, 5c3, 5h1 and 7a1, show strong to moderate hydrogen bonding and hydrophobic interactions (pi-pi stacked, pi-pi T-shaped, pi-sigma and pi-alkyl). The stability provided from such interactions translate into greater antiviral activity or inhibitory effect of the ligands. Assessment of the average free energies of binding of the FDA approved drugs are highly comparable for conformers of a particular inhibitor, indicating similar modes of binding within the pockets.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach
    Gangadharan, Sivakumar
    Ambrose, Jenifer Mallavarpu
    Rajajagadeesan, Anusha
    Kullappan, Malathi
    Patil, Shankargouda
    Gandhamaneni, Sri Harshini
    Veeraraghavan, Vishnu Priya
    Nakkella, Aruna Kumari
    Agarwal, Alok
    Jayaraman, Selvaraj
    Surapaneni, Krishna Mohan
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (11) : 1180 - 1191
  • [42] A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp)
    Ribaudo, Giovanni
    Ongaro, Alberto
    Oselladore, Erika
    Zagotto, Giuseppe
    Memo, Maurizio
    Gianoncelli, Alessandra
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (03): : 1101 - 1108
  • [43] Phytochemical and in silico studies for potential constituents from Centaurium spicatum as candidates against the SARS-CoV-2 main protease and RNA-dependent RNA polymerase
    Allam, Ahmed E.
    Abouelela, Mohamed E.
    Assaf, Hamdy K.
    Sayed, Ahmed M.
    Nafady, Alaa M.
    El-Shanawany, Mohamed A.
    Takano, Fumihide
    Ohta, Tomihisa
    [J]. NATURAL PRODUCT RESEARCH, 2022, 36 (22) : 5724 - 5731
  • [44] Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2
    Bhardwaj, Vijay Kumar
    Singh, Rahul
    Sharma, Jatin
    Rajendran, Vidya
    Purohit, Rituraj
    Kumar, Sanjay
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [45] Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products
    Abbas Khan
    Mazhar Khan
    Shoaib Saleem
    Zainib Babar
    Arif Ali
    Abdul Aziz Khan
    Zain Sardar
    Fahad Hamayun
    Syed Shujait Ali
    Dong-Qing Wei
    [J]. Interdisciplinary Sciences: Computational Life Sciences, 2020, 12 : 335 - 348
  • [46] Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP
    Naydenova, Katerina
    Muir, Kyle W.
    Wu, Long-Fei
    Zhang, Ziguo
    Coscia, Francesca
    Peet, Mathew J.
    Castro-Hartmann, Pablo
    Qian, Pu
    Sader, Kasim
    Dent, Kyle
    Kimanius, Dari
    Sutherland, John D.
    Lowe, Jan
    Barford, David
    Russo, Christopher J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (07)
  • [47] Biochemical characterization of naturally occurring mutations in SARS-CoV-2 RNA-dependent RNA polymerase
    Danda, Matej
    Klimesova, Anna
    Kuskova, Klara
    Dostalkova, Alzbeta
    Pagacova, Aneta
    Prchal, Jan
    Kapisheva, Marina
    Ruml, Tomas
    Rumlova, Michaela
    [J]. PROTEIN SCIENCE, 2024, 33 (09)
  • [48] Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products
    Khan, Abbas
    Khan, Mazhar
    Saleem, Shoaib
    Babar, Zainib
    Ali, Arif
    Khan, Abdul Aziz
    Sardar, Zain
    Hamayun, Fahad
    Ali, Syed Shujait
    Wei, Dong-Qing
    [J]. INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES, 2020, 12 (03) : 335 - 348
  • [49] Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase
    Xu, Tiantian
    Zhang, Lu
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2023, 21 : 4385 - 4394
  • [50] SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19
    Vicenti, Ilaria
    Zazzi, Maurizio
    Saladini, Francesco
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2021, 31 (04) : 325 - 337